We are live on
!
Find out more
N
Nuveen Portfolio holdings
AUM
$369B
1-Year Est. Return
31.66%
This Fund
S&P 500
This Quarter
Est. Return
+10%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$264B
AUM Growth
+$16.6B
(+6.7%)
Cap. Flow
-$3.28B
Cap. Flow
% of AUM
-1.24%
Top 10 Holdings %
Top 10 Hldgs %
18.75%
Holding
3,331
New
118
Increased
1,090
Reduced
1,840
Closed
95
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$1.03B |
| 2 |
Bristol-Myers Squibb
BMY
|
+$649M |
| 3 |
NVIDIA
NVDA
|
+$329M |
| 4 |
AT&T
T
|
+$316M |
| 5 |
Tesla
TSLA
|
+$313M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cisco
CSCO
|
+$474M |
| 2 |
CELG
Celgene Corp
CELG
|
+$421M |
| 3 |
Broadcom
AVGO
|
+$411M |
| 4 |
Netflix
NFLX
|
+$387M |
| 5 |
Apple
AAPL
|
+$372M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.51% |
| 2 | Financials | 14.64% |
| 3 | Healthcare | 13.3% |
| 4 | Consumer Discretionary | 10.29% |
| 5 | Communication Services | 9.4% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
Amgen
AMGN
$219B
| $1.01B | 0.38% |
4,201,016
-1,283,534
| -23% | -$283M |
|
52
American Express
AXP
$231B
| $992M | 0.38% |
7,969,925
+149,491
| +2% | +$17.9M |
|
53
Philip Morris
PM
$293B
| $988M | 0.37% |
11,613,360
+279,054
| +2% | +$23M |
|
54
S&P Global
SPGI
$119B
| $988M | 0.37% |
3,618,230
+56,905
| +2% | +$14.8M |
|
55
NextEra Energy
NEE
$176B
| $966M | 0.37% |
15,960,676
-627,996
| -4% | -$36.7M |
|
56
American Tower
AMT
$79.8B
| $963M | 0.37% |
4,191,369
-20,206
| -0.5% | -$4.4M |
|
57
Abbott
ABT
$187B
| $954M | 0.36% |
10,977,838
-769,059
| -7% | -$64.4M |
|
58
Prologis
PLD
$132B
| $893M | 0.34% |
10,022,183
+54,223
| +0.5% | +$4.81M |
|
59
Intuitive Surgical
ISRG
$132B
| $878M | 0.33% |
4,454,688
-189,705
| -4% | -$35.5M |
|
60
Mondelez International
MDLZ
$80.1B
| $850M | 0.32% |
15,426,183
+526,136
| +4% | +$28.1M |
|
61
Applied Materials
AMAT
$419B
| $837M | 0.32% |
13,708,691
+2,835,684
| +26% | +$159M |
|
62
Morgan Stanley
MS
$336B
| $832M | 0.32% |
16,266,898
+1,412,864
| +10% | +$66.9M |
|
63
Illumina
ILMN
$29.3B
| $819M | 0.31% |
2,537,200
+157,756
| +7% | +$47.8M |
|
64
ServiceNow
NOW
$121B
| $802M | 0.3% |
14,204,060
-3,098,920
| -18% | -$163M |
|
|
65
Broadcom
AVGO
$2T
| $792M | 0.3% |
25,050,090
-13,549,750
| -35% | -$411M |
|
66
CVS Health
CVS
$123B
| $790M | 0.3% |
10,627,728
-1,529,619
| -13% | -$107M |
|
67
Medtronic
MDT
$110B
| $772M | 0.29% |
6,802,944
-218,755
| -3% | -$24M |
|
68
Lowe's Companies
LOW
$122B
| $743M | 0.28% |
6,203,660
+156,840
| +3% | +$17.9M |
|
69
Cigna
CI
$72.7B
| $728M | 0.28% |
3,560,825
+824,500
| +30% | +$151M |
|
70
Qualcomm
QCOM
$168B
| $723M | 0.27% |
8,192,042
+692,411
| +9% | +$57.9M |
|
71
US Bancorp
USB
$99.4B
| $715M | 0.27% |
12,051,621
+149,534
| +1% | +$8.65M |
|
72
Booking.com
BKNG
$156B
| $710M | 0.27% |
8,646,575
+2,378,575
| +38% | +$187M |
|
73
Lockheed Martin
LMT
$135B
| $677M | 0.26% |
1,738,460
-19,269
| -1% | -$7.39M |
|
74
Edwards Lifesciences
EW
$51.5B
| $674M | 0.26% |
8,670,765
-2,574,039
| -23% | -$201M |
|
75
Goldman Sachs
GS
$301B
| $670M | 0.25% |
2,915,111
+814,010
| +39% | +$177M |
|
Similar funds
VFT
Nuveen's Q4 2019 Portfolio in Review
As of Q4 2019, Nuveen held 3,331 positions worth $264B, up 6.7% from $247B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Nuveen's Q4 2019 filing shows 118 new, 1,090 increased, 1,840 reduced and 95 closed positions. Its largest new stake was iShares iBoxx $ Investment Grade Corporate Bond ETF: 8,077,161 shares worth $1.03B. The largest sale was Cisco, an estimated $474M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Financials and Healthcare.
- Nuveen's largest Q4 2019 buy was iShares iBoxx $ Investment Grade Corporate Bond ETF: 8,077,161 shares worth $1.03B.
- Nuveen added most to Bristol-Myers Squibb in Q4 2019, an estimated $649M increase.
- Nuveen's biggest Q4 2019 reduction was Cisco, cutting an estimated $474M.
- Nuveen fully exited Celgene Corp in Q4 2019, selling an estimated $421M.
- Nuveen's ten largest holdings make up 19% of its $264B portfolio in Q4 2019.
- Nuveen opened 118 new positions and closed 95 in Q4 2019.
- Nuveen's portfolio value rose 6.7% quarter-over-quarter to $264B.
Based on Nuveen's 13F filing for Q4 2019, filed 14 Feb 2020.